Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Island Pharmaceuticals Ltd ( (AU:ILA) ).
Island Pharmaceuticals has issued 335,000 fully paid ordinary shares following the exercise of unlisted options at an issue price of $0.21 per share, expanding its share capital without undertaking a separate disclosure document. The company confirmed it is up to date with its financial reporting and continuous disclosure requirements and stated there is no undisclosed price-sensitive information, signalling regulatory compliance and transparency for existing and prospective investors.
More about Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd is an Australian-listed biopharmaceutical company trading on the ASX under the ticker ILA. The company is focused on developing pharmaceutical products, with its operations governed by Australian corporate and securities regulations, including compliance with financial reporting and continuous disclosure obligations under the Corporations Act.
Average Trading Volume: 342,549
Technical Sentiment Signal: Buy
Current Market Cap: A$110.8M
For detailed information about ILA stock, go to TipRanks’ Stock Analysis page.